Treatment modalities for autoimmune diseases
Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.
1. A composition for treating an autoimmune disease, said composition comprising therapeutically effective amounts of (a) a compound selected from the group consisting of dihydro-isohumulone, dihydro-isocohumulone, dihydro-isoadhumulone, tetrahydro-isohumulone, tetrahydro-isocohumulone, tetrahydro-isoadhumulone, hexahydro-isohumulone, hexahydro-isocohumulone, and hexahydro-isoadhumulone (b) at least one mineral, and (c) at least one vitamin, wherein said composition is in tablet or capsule form for administration to a subject suffering from an autoimmune disease.
2. The composition of claim 1 , wherein the at least one mineral is selected from the group consisting of calcium, selenium, zinc, copper, iron, chromium, magnesium, manganese, vanadium, molybdenum, and boron.
3. The composition of claim 1 , wherein the at least one mineral is selected from the group consisting of selenium and zinc.
4. The composition of claim 1 , wherein the at least one vitamin is selected from the group consisting of Vitamin A, Vitamin B, Vitamin C, Vitamin D, Vitamin E, Vitamin K, biotin, folate, pantothenic acid, para-aminobenzoic acid, and betaine.
5. The composition of claim 1 , wherein the at least one vitamin is Vitamin D.
6. The composition of claim 1 , wherein the composition comprises about 0.5 to 10,000 mg of the compound.
7. The composition of claim 1 , wherein the composition comprises about 50 to 7,500 mg of the compound.
8. The composition of claim 1 , wherein the composition further comprises a pharmaceutically acceptable carrier.